# Clinical Trial Landscape: 11_young_sarcoma_treatment_naive

*Generated: 2026-01-05 18:32:43*

## Summary

- **Total Trials**: 100
- **Flagged for Review**: 0
- **Search Terms Used**: 11

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Not Applicable | 28 | █████ 28.0% |
| Phase 1 | 22 | ████ 22.0% |
| Unknown | 17 | ███ 17.0% |
| Phase 1/Phase 2 | 12 | ██ 12.0% |
| Phase 2 | 10 | ██ 10.0% |
| Phase 3 | 9 | █ 9.0% |
| Phase 4 | 2 |  2.0% |

## Status Distribution

- **Recruiting**: 95 (95.0%)
- **Not yet recruiting**: 3 (3.0%)
- **Enrolling by invitation**: 2 (2.0%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| National Cancer Institute (NCI) | 7 |
| M.D. Anderson Cancer Center | 4 |
| Mayo Clinic | 3 |
| Merck Sharp & Dohme LLC | 3 |
| University of Colorado, Denver | 2 |
| University of Washington | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| The University of Texas Health Science Center at S | 2 |
| Northwestern University | 1 |
| University of Nebraska | 1 |
| Massachusetts General Hospital | 1 |
| Washington University School of Medicine | 1 |
| Population Health Research Institute | 1 |
| Ohio State University | 1 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Biospecimen Collection | 5 |
| Placebo | 5 |
| Cyclophosphamide | 4 |
| Temozolomide | 4 |
| BGB-11417 | 3 |
| Bone Marrow Aspiration | 2 |
| Bone Marrow Biopsy | 2 |
| Pembrolizumab | 2 |
| Computed Tomography | 2 |
| Pegylated Liposomal Doxorubicin Hydrochloride | 2 |
| Gemcitabine | 2 |
| Abemaciclib | 2 |
| Bomedemstat | 2 |
| riliprubart | 2 |
| Atezolizumab | 2 |
| Ca-125 | 1 |
| screening questionnaire administration | 1 |
| Surgery | 1 |
| Caloric Restriction Diet | 1 |
| EOS imaging | 1 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 100 |
| Canada | 15 |
| Australia | 15 |
| Italy | 14 |
| Spain | 14 |
| United Kingdom | 13 |
| Germany | 12 |
| South Korea | 12 |
| France | 12 |
| Taiwan | 10 |
| Japan | 9 |
| Netherlands | 8 |
| Poland | 8 |
| China | 7 |
| Turkey (Türkiye) | 7 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| SS18-SSX fusion | manual | 1.0 |
| SS18-SSXfusion | manual | 0.9 |
| SS18-SSX-fusion | manual | 0.9 |
| synovial sarcoma | manual | 1.0 |
| SS18-SSX fusion synovial sarcoma | manual | 1.0 |
| SS18-SSX1 fusion synovial sarcoma | llm | 0.9 |
| SS | llm | 0.8 |
| soft tissue sarcoma | llm | 0.8 |
| SS18-SSX1 fusion | llm | 0.9 |
| SS18-SSX1fusion | llm | 0.8 |
| SS18-SSX1-fusion | llm | 0.8 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT06625190](https://clinicaltrials.gov/study/NCT06625190) | Phase 1/Phase 2 | Recruiting | University of Florid... | Allogeneic Stem Cell Transplantatio... |
| [NCT06492954](https://clinicaltrials.gov/study/NCT06492954) | Phase 1 | Recruiting | Emory University | Phase 1b Trial of Atezolizumab in C... |
| [NCT07069517](https://clinicaltrials.gov/study/NCT07069517) | Not Applicable | Recruiting | Palo Alto Veterans I... | Accelerated Treatment for Co-occurr... |
| [NCT07049848](https://clinicaltrials.gov/study/NCT07049848) | Phase 2 | Recruiting | M.D. Anderson Cancer... | SATURN-STS: Phase II Study of Neoad... |
| [NCT06886152](https://clinicaltrials.gov/study/NCT06886152) | Not Applicable | Not yet recruiting | Kessler Foundation | Transcutaneous Spinal Stimulation a... |
| [NCT06910657](https://clinicaltrials.gov/study/NCT06910657) | Phase 1 | Recruiting | ViroMissile, Inc. | A First-in-human, Phase I, Multi-ce... |
| [NCT06661915](https://clinicaltrials.gov/study/NCT06661915) | Phase 2 | Recruiting | National Cancer Inst... | A Randomized Phase 2 Trial of ASTX7... |
| [NCT07055854](https://clinicaltrials.gov/study/NCT07055854) | Phase 1 | Not yet recruiting | Oregon State Univers... | Virtual Mindful After Cancer Interv... |
| [NCT06946225](https://clinicaltrials.gov/study/NCT06946225) | Phase 1 | Recruiting | Immatics US, Inc. | A First-in-human, Open-label Trial ... |
| [NCT07058064](https://clinicaltrials.gov/study/NCT07058064) | Not Applicable | Recruiting | Mayo Clinic | WATCH (Wearable Artificial inTellig... |
| [NCT06371768](https://clinicaltrials.gov/study/NCT06371768) | Not Applicable | Recruiting | Duke University | Symptom Management and Transitionin... |
| [NCT06748872](https://clinicaltrials.gov/study/NCT06748872) | Phase 1 | Not yet recruiting | Medigene AG | EPITOME-1015-I: a Phase I Study to ... |
| [NCT06630325](https://clinicaltrials.gov/study/NCT06630325) | Phase 2 | Recruiting | OHSU Knight Cancer I... | Serial Measurements of Molecular an... |
| [NCT06797999](https://clinicaltrials.gov/study/NCT06797999) | Phase 1/Phase 2 | Recruiting | Adcendo ApS | A First-in-human, Phase 1/2, Multic... |
| [NCT06935370](https://clinicaltrials.gov/study/NCT06935370) | Phase 3 | Recruiting | Boehringer Ingelheim | EASi-HF Reduced - A Phase III Doubl... |
| [NCT06876740](https://clinicaltrials.gov/study/NCT06876740) | Not Applicable | Recruiting | University of Colora... | Project Safe Guard-Trauma (PSG-T): ... |
| [NCT06798012](https://clinicaltrials.gov/study/NCT06798012) | Phase 2 | Recruiting | Takeda | A Phase 2, Open-label, Proof-of-Con... |
| [NCT06953687](https://clinicaltrials.gov/study/NCT06953687) | Not Applicable | Recruiting | The University of Te... | Implementing and Evaluating a Patie... |
| [NCT06728774](https://clinicaltrials.gov/study/NCT06728774) | Not Applicable | Recruiting | Portland VA Medical ... | Cognitive Rehabilitation for Vetera... |
| [NCT06884618](https://clinicaltrials.gov/study/NCT06884618) | Phase 1 | Recruiting | Hoffmann-La Roche | A Phase I Dose Escalation and Expan... |
| [NCT06970301](https://clinicaltrials.gov/study/NCT06970301) | Phase 1 | Recruiting | UCB Biopharma SRL | A Single-center, Placebo-controlled... |
| [NCT06598189](https://clinicaltrials.gov/study/NCT06598189) | Not Applicable | Recruiting | Felicia Chu | Real-time Seizure Detection, Classi... |
| [NCT06564948](https://clinicaltrials.gov/study/NCT06564948) | Not Applicable | Recruiting | Cambridge Health All... | Improving Mental Health Treatment f... |
| [NCT06722755](https://clinicaltrials.gov/study/NCT06722755) | Not Applicable | Recruiting | University of Washin... | Optimizing Adherence to the Treatme... |
| [NCT06801678](https://clinicaltrials.gov/study/NCT06801678) | N/A | Recruiting | The Eye institute of... | Refractive Outcomes Utilizing Two S... |
| [NCT05904093](https://clinicaltrials.gov/study/NCT05904093) | Phase 1 | Recruiting | National Heart, Lung... | A Phase I Study to Evaluate the Saf... |
| [NCT06551987](https://clinicaltrials.gov/study/NCT06551987) | Not Applicable | Recruiting | The University of Te... | Cognitive Behavioral Therapy for In... |
| [NCT06644755](https://clinicaltrials.gov/study/NCT06644755) | Phase 1 | Recruiting | Daiichi Sankyo | Phase 1, Open-Label, Multicenter, F... |
| [NCT04890093](https://clinicaltrials.gov/study/NCT04890093) | Phase 1/Phase 2 | Recruiting | National Cancer Inst... | Phase 1/2 Study of Vincristine and ... |
| [NCT06421350](https://clinicaltrials.gov/study/NCT06421350) | Not Applicable | Recruiting | Scripps Health | Efficacy of Closed-Loop Spinal Cord... |
| [NCT06290141](https://clinicaltrials.gov/study/NCT06290141) | Phase 3 | Recruiting | Sanofi | A Phase 3, Randomized, Double-blind... |
| [NCT06524635](https://clinicaltrials.gov/study/NCT06524635) | Phase 2 | Recruiting | AbbVie | A Multicenter Open-Label Interventi... |
| [NCT06283472](https://clinicaltrials.gov/study/NCT06283472) | Not Applicable | Recruiting | Indiana University | Enhancing Prospective Thinking in E... |
| [NCT06351631](https://clinicaltrials.gov/study/NCT06351631) | Phase 3 | Recruiting | Merck Sharp & Dohme ... | A Multicenter, Open-Label, Extensio... |
| [NCT06343402](https://clinicaltrials.gov/study/NCT06343402) | Phase 1 | Recruiting | TheRas, Inc., d/b/a ... | A Phase 1a/1b Open-Label Study Eval... |
| [NCT06359574](https://clinicaltrials.gov/study/NCT06359574) | Not Applicable | Enrolling by invitation | University of North ... | Development and Implementation of a... |
| [NCT06083883](https://clinicaltrials.gov/study/NCT06083883) | Phase 1 | Recruiting | M.D. Anderson Cancer... | Phase I/Ib Study of Adoptive NK Exp... |
| [NCT06409013](https://clinicaltrials.gov/study/NCT06409013) | N/A | Recruiting | Mayo Clinic | Sarcoma Resection Guided by Intraop... |
| [NCT06242470](https://clinicaltrials.gov/study/NCT06242470) | Phase 1 | Recruiting | MacroGenics | A Phase 1/1b First-in-Human, Open L... |
| [NCT05767658](https://clinicaltrials.gov/study/NCT05767658) | Not Applicable | Recruiting | University of Virgin... | Support Via Online Social Networks ... |
| [NCT05853575](https://clinicaltrials.gov/study/NCT05853575) | Phase 2 | Recruiting | Mirati Therapeutics ... | A Randomized Study of Two Dosing Re... |
| [NCT05711615](https://clinicaltrials.gov/study/NCT05711615) | Phase 1 | Recruiting | National Cancer Inst... | A Phase 1 Study of Peposertib (M381... |
| [NCT05958316](https://clinicaltrials.gov/study/NCT05958316) | Not Applicable | Recruiting | Virginia Commonwealt... | A Randomized Controlled Trial Using... |
| [NCT06079879](https://clinicaltrials.gov/study/NCT06079879) | Phase 3 | Recruiting | Merck Sharp & Dohme ... | A Phase 3, Randomized, Open-label, ... |
| [NCT06054555](https://clinicaltrials.gov/study/NCT06054555) | Phase 3 | Recruiting | Amgen | A Randomized, Double-Blind Study Ev... |
| [NCT06072131](https://clinicaltrials.gov/study/NCT06072131) | Phase 3 | Recruiting | Acrotech Biopharma I... | A Phase 3, Randomized, Open-Label S... |
| [NCT05730036](https://clinicaltrials.gov/study/NCT05730036) | Phase 3 | Recruiting | Regeneron Pharmaceut... | An Open-label, Randomized, Phase 3 ... |
| [NCT05642455](https://clinicaltrials.gov/study/NCT05642455) | Phase 1/Phase 2 | Recruiting | Adaptimmune | A Phase 1/2 Open Label, Basket Stud... |
| [NCT06021626](https://clinicaltrials.gov/study/NCT06021626) | Phase 1 | Recruiting | Memorial Sloan Kette... | A Phase I Trial of CRD3874-SI, a ST... |
| [NCT06056323](https://clinicaltrials.gov/study/NCT06056323) | Phase 1/Phase 2 | Recruiting | Shanghai Huaota Biop... | A Phase I/II, Open-label, Multicent... |

*... and 50 more trials (see trials.csv for full list)*
